Q3 2024 Earnings Call Transcript November 13, 2024 Mersana Therapeutics, Inc. misses on earnings expectations. Reported EPS ...

Givastomig data presented at ESMO 2024 and SITC 2024 highlights encouraging monotherapy data On track to dose first patient ...

Expects to deliver three Investigational New Drug (IND) applications in next three years based on next-generation ADC technology -- Two new ...

Givastomig data presented at ESMO 2024 and SITC 2024 highlights encouraging monotherapy data On track to dose first patient in randomized Phase 2 study of uliledlimab ...

“During the third quarter and at the recent SITC conference, we presented data from our Phase 1a ... Provide updated RFS and OS data in an oral presentation at the 2024 ESMO Immuno-Oncology Congress, ...

November 24 to 26, 2024 Intelligent Automation Summit DACH - 30% Discount: MKT30 Berlin, Germany November 24 to 26, 2024 BPM 4.0 Summit DACH - 30% Discount: MKT30 Berlin, Germany ...